Centro Integral de Cancerología

What Centro Integral de Cancerología does

Centro Integral de Cancerología (CICTOLUCA) is a private, single-site comprehensive cancer center located in Madero, Metepec, Estado de México, serving the Toluca metropolitan area. Founded in 2019 and operating with 51–100 employees, the center delivers integrated oncology care spanning radiotherapy, chemotherapy, immunotherapy, targeted therapy, hormone therapy, PET-CT, mammography, tomography, laboratory diagnostics, pathology, and oncology consultation. Its clinical technology platform is built around capital-intensive medical hardware: a medical linear accelerator for radiation delivery, a high-definition tomograph for treatment planning, dosimetric systems for virtual treatment modeling, dual-modality SPECT/CT and PET/CT imaging units with FDG tracers, mammography equipment, and laboratory diagnostic infrastructure. Treatment workflows follow a multidisciplinary model involving medical oncologists, nuclear medicine physicians, radiologists, medical physicists (including a designated Radiation Safety Expert), and radiotherapy technicians.

The business operates on a fee-for-service revenue model, billing patients (or their insurers) per procedure — radiotherapy sessions, chemotherapy administrations, imaging studies, and lab tests are each discrete billable services. Patient acquisition is driven by physician referrals, direct appointment booking via the company website (centrocancerologia.mx, "AGENDAR CITA"), and walk-in consultations; the center also maintains organic social media presence on Facebook, LinkedIn, and Instagram under the CICTOLUCA brand. All services are delivered in person at the Metepec facility — there is no telemedicine or digital self-service channel. Pricing is not publicly disclosed. The company is privately held, with no disclosed parent company, institutional investors, funding rounds, partnerships, patents, or industry awards in the available source data.

The customer base is entirely B2C, comprising cancer patients requiring diagnosis, treatment, or monitoring, and women aged 40–69 seeking breast cancer screening (screening and diagnostic mammography). The center's value proposition is consolidated multidisciplinary cancer care under one roof, with approximately 15-minute radiotherapy sessions, virtual treatment planning, and personalized care emphasizing active listening and transparency. No revenue figures, headcount growth trends, or geographic expansion beyond a single Estado de México location are disclosed in the source material.

Name

Centro Integral de Cancerología

Legal name

Centro Integral de Cancerología

Website

https://centrocancerologia.mx

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

51–100 employees

Short description

Centro Integral de Cancerología is a private single-site cancer center in Metepec, Estado de México, offering radiotherapy, chemotherapy, PET-CT, mammography, laboratory, and pathology services to cancer patients across the Toluca metropolitan area on a fee-for-service basis.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Outpatient Care Centers (6214), Diagnostic Imaging Centers (621512)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro industry

PRIMARYHLAFABAI

Ambulatory Oncology Centers (Outpatient Chemo/Radiation)

Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers

SECONDARYHLAFAKAB

Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology)

Healthcare & Life Sciences/Healthcare Providers & Systems/Diagnostic & Imaging Centers

SECONDARYHLAKAFAB

Medical Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

Keywords

• Radiation oncology services
• Cancer diagnostic imaging
• Chemotherapy treatment
• Mammography screening
• Nuclear medicine imaging

Headquarters

HQ city

Metepec

HQ country

Mexico

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Medical Oncology Services: The center generates revenue through direct provision of fee-for-service medical oncology procedures including radiotherapy sessions, chemotherapy administration, PET-CT, mammography, laboratory tests, tomography, and pathology services. Each treatment modality (radiotherapy, chemotherapy, etc.) is billed as a distinct clinical service, with the number of radiotherapy sessions and specific treatment protocols determining total cost per patient.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Centro Integral de Cancerología is a single-site cancer treatment center that provides comprehensive oncological diagnosis and therapy, including radiotherapy delivered via a medical linear accelerator, chemotherapy and immunotherapy administration, PET-CT and tomography imaging, mammography, laboratory diagnostics, pathology, and specialized oncology consultations. The center serves adult cancer patients in the Toluca/Metepec region of Estado de México, combining multiple treatment and imaging modalities under one roof with a multidisciplinary team of medical oncologists, nuclear medicine physicians, radiologists, and medical physicists.

Product overview

Centro Integral de Cancerología is a comprehensive cancer care center offering an integrated suite of oncology services. The facility operates as a single-site cancer center providing diagnostic imaging (PET-CT, Tomography, Mammography), laboratory testing, and multiple treatment modalities including Radiation Therapy (Radioterapia), Chemotherapy (Quimioterapia), Immunotherapy, Targeted Therapies, and Hormone Therapy. Additional services include Oncology Consultation and Pathology. The center features specialized medical staff including medical oncologists, nuclear medicine physicians, radiologists, and medical physicists, utilizing advanced linear accelerator technology and high-definition imaging equipment for precise cancer diagnosis and treatment.

Differentiator

Problem solved

Functional benefit

Products and services

• Radioterapia (Radiotherapy) Cancer treatment using ionizing radiation delivered via a medical linear accelerator, with high-definition tomographic imaging for treatment planning and precision delivery to target tumors while sparing healthy organs. Sessions last approximately 15 minutes and the number of sessions is determined by the treating physician based on diagnosis.
• PET-CT (Positron Emission Tomography-Computed Tomography) Nuclear medicine imaging that combines positron emission tomography with computed tomography using radioactive tracers such as Fluorodeoxyglucose F-18 (FDG) to detect early manifestations of disease, evaluate tumor malignancy, determine cancer staging, and monitor treatment response.
• Laboratorio (Laboratory Services) Clinical laboratory testing services including blood, urine, and tissue analysis for cancer screening, diagnosis through tumor markers, staging, treatment planning, and monitoring during cancer treatment.
• Mastografía (Mammography) X-ray examination of the breast recommended for women aged 40-69 to detect abnormalities, including screening mammography for asymptomatic women and diagnostic mammography for women with signs or symptoms of breast cancer such as lumps, skin changes, nipple discharge, or breast pain.
• Quimioterapia (Chemotherapy) Cancer treatment using drugs to destroy cancer cells, administered orally, intravenously, via injection, intrathecally, intraperitoneally, intra-arterially, or topically, following individualized treatment plans based on cancer type and staging.
• Inmunoterapia (Immunotherapy) Biological therapy that helps the immune system fight cancer using substances produced by living organisms, enhancing the body's natural defenses against cancer cells.
• Terapias Dirigidas (Targeted Therapies) Precision medicine approach targeting specific cellular changes that promote cancer growth, division, and spread, acting on identified genetic mutations and blocking their effects.
• Hormonoterapia (Hormone Therapy) Endocrine therapy that slows or stops cancer growth that uses hormones to develop, primarily used for prostate and breast cancers, typically administered alongside other cancer treatments.
• Consulta Oncológica (Oncology Consultation) Specialized oncology medical consultations provided by oncologist physicians for cancer diagnosis, treatment planning, and patient follow-up.
• Tomografía (Tomography/CT) High-definition computed tomography scanning for diagnostic imaging, treatment planning, and follow-up assessments using advanced imaging technology.
• Patología (Pathology) Medical pathology services for tissue analysis and cancer diagnosis as part of the comprehensive cancer care offering.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Broad incumbents

• Hospital Zambrano Hellion (TecSalud Cancer Center): Private quaternary hospital in Monterrey with dedicated oncology and radiotherapy programs using linear accelerators and advanced imaging. Directly comparable in offering a multi-modality private cancer center, though anchored in a different region and at larger scale.
• City of Hope (formerly Cancer Treatment Centers of America): U.S. specialty cancer hospital system delivering integrated medical oncology, radiation oncology, imaging and supportive care. Useful benchmark for the multidisciplinary cancer-center model that Centro Integral de Cancerología is replicating at smaller scale.
• Centro Médico ABC: Major private hospital system in Mexico City with oncology, radiotherapy, PET-CT and imaging capabilities. Overlapping service mix with the subject company, but part of a much broader general hospital portfolio.
• Instituto Nacional de Cancerología (INCAN): Mexico's flagship public cancer hospital in Mexico City providing radiotherapy, chemotherapy, PET-CT, and pathology. Comparable to Centro Integral de Cancerología in service breadth, but operates at national referral scale rather than a single Estado de México site.
• Médica Sur: Large private hospital in Mexico City with an oncology department including chemotherapy, radiotherapy, and imaging services. Comparable multi-modality cancer offering embedded in a broader tertiary hospital system.
• MD Anderson Cancer Center: Global leader in comprehensive cancer care with radiotherapy, chemotherapy, immunotherapy, PET-CT, and pathology integration. Sets the international benchmark for the full-spectrum oncology service model that Centro Integral de Cancerología is pursuing.

Direct peers

• Oncosur (Centro Oncológico del Sur): Specialized oncology provider in Mexico offering multi-modality cancer care including radiotherapy, chemotherapy, and imaging. Closest direct peer in terms of being a focused private oncology center rather than a general hospital.

Others

• Laboratorio Chopo: Large Mexican laboratory and diagnostic imaging chain with extensive outpatient footprint. Directly comparable to the laboratory, mammography, and tomography components of Centro Integral de Cancerología's offering, and could compete for downstream screening volumes.

Emerging players

• Salud Digna: Mexican low-cost diagnostic chain offering mammography, laboratory, and imaging services nationwide. Comparable on the diagnostics side (mammography, lab, imaging) but lacks radiotherapy and chemotherapy, making it more of an upstream feeder/competitor.

Regional players

• Hospital Angeles Metepec: General private hospital located in the same Metepec/Toluca corridor as Centro Integral de Cancerología. Although not an oncology specialty center, it competes for the same Estado de México patient base and could refer into or compete against the subject's cancer services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/CICTOLUCA
• LinkedInlinkedin.com/company/cictoluca
• Instagraminstagram.com/cictoluca

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centro Integral de Cancerología